137 related articles for article (PubMed ID: 2555874)
1. Platelet-activating factor and cytokine interactions in shock.
Hosford D; Paubert-Braquet M; Braquet P
Resuscitation; 1989 Dec; 18(2-3):207-18. PubMed ID: 2555874
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of the novel platelet activating factor receptor antagonist, 1-ethyl-2-[N-(2-methoxy)benzoyl-N-[(2R)-2-methoxy-3-(4- octadecylcarbamoyloxy) piperidinocarbonyloxypropyloxy]carbonyl] aminomethyl-pyridinium chloride, in several experimentally induced shock models.
Nagaoka J; Harada K; Kimura A; Kobayashi S; Murakami M; Yoshimura T; Yamada K; Asano O; Katayama K; Yamatsu I
Arzneimittelforschung; 1991 Jul; 41(7):719-24. PubMed ID: 1663352
[TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor in cardiovascular stress situations.
Rabinovici R; Yue TL; Feuerstein G
Lipids; 1991 Dec; 26(12):1257-63. PubMed ID: 1819713
[TBL] [Abstract][Full Text] [Related]
4. PAF/cytokine auto-generated feedback networks in microvascular immune injury: consequences in shock, ischemia and graft rejection.
Braquet P; Paubert-Braquet M; Bourgain RH; Bussolino F; Hosford D
J Lipid Mediat; 1989; 1(2):75-112. PubMed ID: 2519889
[TBL] [Abstract][Full Text] [Related]
5. Interactions between platelet-activating factor and prostanoids during mesenteric ischemia-reperfusion-induced shock in the anesthetized dog.
Filep JG; Braquet P; Mózes T
Circ Shock; 1991 Sep; 35(1):1-8. PubMed ID: 1742856
[TBL] [Abstract][Full Text] [Related]
6. Induction of tissue injury and altered cardiovascular performance by platelet-activating factor: relevance to multiple systems organ failure.
Lefer AM
Crit Care Clin; 1989 Apr; 5(2):331-52. PubMed ID: 2650821
[TBL] [Abstract][Full Text] [Related]
7. Platelet activating factor and its role in trauma, shock, and sepsis.
Ayala A; Chaudry IH
New Horiz; 1996 May; 4(2):265-75. PubMed ID: 8774801
[TBL] [Abstract][Full Text] [Related]
8. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat.
Toth PD; Mikulaschek AW
Circ Shock; 1986; 20(3):193-203. PubMed ID: 3802423
[TBL] [Abstract][Full Text] [Related]
9. Involvement of platelet-activating factor (PAF) in septic shock and priming as indicated by the effect of hetrazepinoic PAF antagonists.
Heuer HO
Lipids; 1991 Dec; 26(12):1369-73. PubMed ID: 1819735
[TBL] [Abstract][Full Text] [Related]
10. Platelet activating factor (PAF). A review of its effects, antagonists and possible future clinical implications (Part I).
Koltai M; Hosford D; Guinot P; Esanu A; Braquet P
Drugs; 1991 Jul; 42(1):9-29. PubMed ID: 1718687
[TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor and shock.
Feuerstein G; Siren AL
Prog Biochem Pharmacol; 1988; 22():181-90. PubMed ID: 3043432
[TBL] [Abstract][Full Text] [Related]
12. Platelet activating factor is one of the mediators involved in endotoxic shock in pigs.
Mózes T; Heiligers JP; Tak CJ; Zijlstra FJ; Ben-Efraim S; Saxena PR; Bonta IL
J Lipid Mediat; 1991 Nov; 4(3):309-25. PubMed ID: 1764577
[TBL] [Abstract][Full Text] [Related]
13. Detection of platelet-activating factor during traumatic shock.
Stahl GL; Craft DV; Lento PH; Lefer AM
Circ Shock; 1988 Nov; 26(3):237-44. PubMed ID: 3208421
[TBL] [Abstract][Full Text] [Related]
14. Pooling of blood in postischemic shock is modulated by platelet-activating factor (PAF).
Sagach VF; Dmitrieva AV; Braquet P
Lipids; 1991 Dec; 26(12):1400-3. PubMed ID: 1819740
[TBL] [Abstract][Full Text] [Related]
15. [Experimental study on platelet activating factor and systemic circulatory failure caused by ischemic liver].
Fukuoka T; Nakajima Y; Nakano H; Kenmochi T; Hayashi R; Suzuki S; Amemiya H
Nihon Geka Gakkai Zasshi; 1992 Dec; 93(12):1474-80. PubMed ID: 1287460
[TBL] [Abstract][Full Text] [Related]
16. Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists.
Wallace JL; Steel G; Whittle BJ; Lagente V; Vargaftig B
Gastroenterology; 1987 Oct; 93(4):765-73. PubMed ID: 3305134
[TBL] [Abstract][Full Text] [Related]
17. The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis.
Zimmerman GA; McIntyre TM; Prescott SM; Stafforini DM
Crit Care Med; 2002 May; 30(5 Suppl):S294-301. PubMed ID: 12004251
[TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor (PAF) antagonistic actions of two new analogs of tetrahydrofurans.
Tsao PS; Stahl GA; Lefer AM; Salvino J; Pietranico S; Nicolaou KC
J Lipid Mediat; 1989; 1(3):189-99. PubMed ID: 2519893
[TBL] [Abstract][Full Text] [Related]
19. Platelets in the immune response: Revisiting platelet-activating factor in anaphylaxis.
Gill P; Jindal NL; Jagdis A; Vadas P
J Allergy Clin Immunol; 2015 Jun; 135(6):1424-32. PubMed ID: 26051949
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K
J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
